Treatment of polymyositis with immunosuppressive drugs.
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003402:Creatine Kinase / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009220:Myositis / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate